China is expected to become the fifth largest pharmaceutical market in the world by 2010. To raise quality standards and competitiveness, their State Food and Drug Administration (SFDA) implemented new inspection guidelines, effective January 1, 2008, replacing the previous GMP guidelines dating back to 1998.

Complete the form below to read the full article of changing GMP in China.